Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other 1Gastrointestinal 1

Conditions

Weight Loss 1Tumor Surgery 1Obesity 1Intermittent Fasting 1Colorectal Neoplasms 1

Interventions

Specimen Handling 111Magnetic Resonance Spectroscopy 111Cyclophosphamide 109pembrolizumab 78Radiotherapy 77Nivolumab 74Cisplatin 69fludarabine 68Carboplatin 61Biopsy 53Paclitaxel 46Standard of Care 45Radiosurgery 41Gemcitabine 41Dexamethasone 40Doxorubicin 38Rituximab 37venetoclax 36Radiation 36Blood Specimen Collection 36fludarabine phosphate 35Cytarabine 35Surveys and Questionnaires 34Bevacizumab 32Capecitabine 31Radiotherapy, Intensity-Modulated 30Ipilimumab 28Etoposide 28durvalumab 27Temozolomide 27

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Caloric Restriction × 30 days × Clear all
NCT05114798 2026-05-22

Time-restricted Eating Versus Daily Continuous Calorie Restriction on Body Weight and Colorectal Cancer Risk Markers

University of Illinois at Chicago

Phase NA Active not recruiting
193 enrolled
GastrointestinalOther

Intermittent Fasting, Obesity, Colorectal Neoplasms, Weight Loss

NCT02792270 2026-05-15

Caloric Restriction In Sarcoma Patients Treated With Pre-Operative RT

Massachusetts General Hospital

Phase NA Recruiting
32 enrolled

Tumor Surgery

Data powered by HemOnc (CC BY 4.0) Colophon âš¡